Hypertrophic Cardiomyopathy
Showing 1 - 25 of 1,327
Hypertrophic Cardiomyopathy Trial in Aswan
Recruiting
- Hypertrophic Cardiomyopathy
-
Aswan, EgyptAswan Heart Centre - Magdi Yacoub Heart Foundation
May 23, 2023
Hypertrophic Cardiomyopathy Trial in Assiut (echocardiography)
Completed
- Hypertrophic Cardiomyopathy
- echocardiography
-
Assiut, EgyptAhmed Abdelkareem
Sep 16, 2023
Mavacamten in Korean Symptomatic Obstructive Hypertrophic
Not yet recruiting
- Obstructive Hypertrophic Cardiomyopathy
-
Seoul, Korea, Republic ofBristol-Myers Squibb YH
Nov 23, 2023
Liwen Procedure in Obstructive Hypertrophic Cardiomyopathy on
Active, not recruiting
- Hypertrophic Cardiomyopathy
- Arrhythmia
- Percutaneous Intramyocardial Septal Radiofrequency Ablation for hypertrophic obstructive cardiomyopathy (Liwen Procedure)
-
Xi'an, Shaanxi, ChinaUltrasound Medicine Department of Xijing Hospital, Fourth Milita
Sep 4, 2023
Implantable Defibrillator User, Hypertrophic Cardiomyopathy, Implantable Cardioverter Ventricular Lead Dysfunction or
Not yet recruiting
- Implantable Defibrillator User
- +3 more
- Implantable Cardioverter Defibrillator implant
- (no location specified)
Jul 3, 2023
Nonobstructive Hypertrophic Cardiomyopathy Trial in Wuhan (Transapical beating-heart septal myectomy)
Recruiting
- Nonobstructive Hypertrophic Cardiomyopathy
- Transapical beating-heart septal myectomy
-
Wuhan, Hubei, ChinaTongji Hospital, Tongji Medical College, Huazhong University of
Jul 11, 2023
Obstructive Hypertrophic Cardiomyopathy Trial (HRS-1893, Placebo)
Not yet recruiting
- Obstructive Hypertrophic Cardiomyopathy
- HRS-1893
- Placebo
- (no location specified)
May 18, 2023
Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy Trial in Anchorage, Portland (Aficamten, Placebo)
Recruiting
- Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
- Aficamten
- Placebo
-
Anchorage, Alaska
- +1 more
Oct 12, 2023
Obesity, Hypertrophic Cardiomyopathy, Cardiovascular Morbidity Trial in Suwon (Diasgnosis of hypertrophic cardiomyopathy)
Recruiting
- Obesity
- +2 more
- Diasgnosis of hypertrophic cardiomyopathy
-
Suwon, Gyeong-gido, Korea, Republic ofAjou University School of Medicine
Dec 11, 2022
Influencing Factors of Liwen Procedure in The Treatment of
Active, not recruiting
- Hypertrophic Obstructive Cardiomyopathy
- Percutaneous Intramyocardial Septal Radiofrequency Ablation for hypertrophic obstructive cardiomyopathy (Liwen Procedure)
-
Xi'an, Shaanxi, ChinaUltrasound Medicine Department of Xijing Hospital, Fourth Milita
Aug 20, 2023
Obstructive Hypertrophic Cardiomyopathy Trial in Milan (pace maker implant guided by acute hemodynamic testing)
Recruiting
- Obstructive Hypertrophic Cardiomyopathy
- pace maker implant guided by acute hemodynamic testing
-
Milan, ItalyIstituto Auxologico Italiano
Mar 6, 2023
Exercise Oxygen Kinetic and Cardiac Output in Hypertrophic
Recruiting
- Cardiopulmonary Exercise Test
- +2 more
-
Milano, Italy
- +2 more
Mar 2, 2023
Hypertrophic Cardiomyopathy Trial in San Francisco (Moderate Intensity Exercise Program)
Recruiting
- Hypertrophic Cardiomyopathy
- Moderate Intensity Exercise Program
-
San Francisco, CaliforniaUniversity of California - San Francisco
Apr 5, 2023
Apical Hypertrophic Cardiomyopathy Trial in Wuhan (Transapical beating-heart septal myectomy)
Recruiting
- Apical Hypertrophic Cardiomyopathy
- Transapical beating-heart septal myectomy
-
Wuhan, Hubei, ChinaTongji Hospital, Tongji Medical College, Huazhong University of
Dec 5, 2022
Atrial Fibrillation, Cardiomyopathy, Hypertrophic, Radiofrequency Ablation Trial in Beijing (hybrid ablation, catheter ablation)
Not yet recruiting
- Atrial Fibrillation
- +2 more
- hybrid ablation
- catheter ablation
-
Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Chi
Jan 30, 2023
Fabry Disease Trial in Roma (Sample blood and 2D-echocardiography with Doppler)
Recruiting
- Fabry Disease
- Sample blood and 2D-echocardiography with Doppler
-
Roma, ItalyFondazione Policlinico Gemelli
Feb 27, 2023
Obstructive Hypertrophic Cardiomyopathy (oHCM) Trial (Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg), Placebo to match
Not yet recruiting
- Obstructive Hypertrophic Cardiomyopathy (oHCM)
- Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg)
- +3 more
- (no location specified)
Mar 2, 2023
Hypertrophic Obstructive Cardiomyopathy Trial
Completed
- Hypertrophic Obstructive Cardiomyopathy
- (no location specified)
Jan 13, 2023
Hypertrophic Cardiomyopathy Trial in Madrid ("Symplicity Spyral" multi-electrode renal denervation catheter and "Symplicity G3"
Recruiting
- Hypertrophic Cardiomyopathy
- "Symplicity Spyral" multi-electrode renal denervation catheter and "Symplicity G3" generator (Renal Denervation System)
-
Madrid, SpainHospital Universitario 12 de Octubre
Nov 26, 2022
Obstructive Hypertrophic Cardiomyopathy
Completed
- Microvascular Dysfunction
- +2 more
-
Beijing, Beijing, ChinaFuwai Hospital, China National Center for Cardiovascular Disease
Jan 11, 2023
Hypertrophic Cardiomyopathy Trial in Bron (CardioInsight™ Noninvasive 3D Mapping System)
Completed
- Hypertrophic Cardiomyopathy
- CardioInsight™ Noninvasive 3D Mapping System
-
Bron, FranceHôpital Louis Pradel
Jan 16, 2023
The SMARTER Cardiomyopathy Study
Not yet recruiting
- Cardiomyopathies
- +2 more
- Blood Sample Collection
- (no location specified)
Feb 20, 2023
Hypertrophic Cardiomyopathy, Hypertrophic Obstructive Cardiomyopathy, Familial Hypertrophic Cardiomyopathy Trial in Canada
Enrolling by invitation
- Hypertrophic Cardiomyopathy
- +3 more
-
Calgary, Alberta, Canada
- +10 more
Oct 17, 2022
Sleep Apnea and Hypertrophic Cardiomyopathy (HCM)
Recruiting
- Hypertrophic Cardiomyopathy
-
Rochester, MinnesotaMayo Clinic
Jul 1, 2022
Cryoenergy to Faciltate Myectomy in Hypertrophic Obstructive
Completed
- Septal Hypertrophy
- Obstructive Hypertrophic Cardiomyopathy
- Cryo myectomy
- Myectomy
-
Milan, ItalyIRCCS Ospedale San Raffaele
Feb 3, 2023